www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/Neurogen-Corporation-Receives-Notice-from-NASDAQ-Regarding-Listing-of-Securities-717888 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Neurogen-Aktie">Neurogen</a> Corporation (NASDAQ: NRGN) announced today that it received a NASDAQ staff determination letter on December ...http://www.finanzen.net/nachricht/Neurogen-Corporation-Receives-Notice-from-NASDAQ-Regarding-Listing-of-Securities-717888http://www.finanzen.net/nachricht/Neurogen-Corporation-Announces-Third-Quarter-2009-Financial-Results-and-Updates-Operations-697541 <style type="text/css"> <!-- .bwcellpaddingbottom1 {padding-bottom: 2.0px} .bwcellpaddingbottom3 {padding-bottom: 4.0px} .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft1 {padding-left: 5.0px} .bwcellpaddingleft2 {padding-left: 10.0px} .bwcellpaddingleft3 ...http://www.finanzen.net/nachricht/Neurogen-Corporation-Announces-Third-Quarter-2009-Financial-Results-and-Updates-Operations-697541http://www.finanzen.net/nachricht/Neurogen-Corporation-Announces-Webcast-of-Third-Quarter-2009-Financial-Results-on-November-6-696089 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Neurogen-Aktie">Neurogen</a> Corporation (NASDAQ:NRGN), a drug development company, announced today that it will release its third ...http://www.finanzen.net/nachricht/Neurogen-Corporation-Announces-Webcast-of-Third-Quarter-2009-Financial-Results-on-November-6-696089http://www.finanzen.net/nachricht/aktien/Neurogen-Corporation-Announces-Second-Quarter-2009-Financial-Results-526937 <style type="text/css"> <!-- .bwcellpaddingbottom1 {padding-bottom: 2.0px} .bwcellpaddingbottom3 {padding-bottom: 4.0px} .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft1 {padding-left: 5.0px} .bwcellpaddingleft2 {padding-left: 10.0px} .bwcellpaddingleft3 ...http://www.finanzen.net/nachricht/aktien/Neurogen-Corporation-Announces-Second-Quarter-2009-Financial-Results-526937http://www.finanzen.net/nachricht/aktien/Neurogen-Corporation-Announces-Webcast-of-Second-Quarter-2009-Financial-Results-on-August-14-2009-522523 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Neurogen Corporation (NASDAQ: NRGN), a drug development company, announced today that it will release its second quarter 2009 financial results ...http://www.finanzen.net/nachricht/aktien/Neurogen-Corporation-Announces-Webcast-of-Second-Quarter-2009-Financial-Results-on-August-14-2009-522523http://www.finanzen.net/nachricht/aktien/Neurogen-Corporation-Announces-First-Quarter-2009-Financial-Results-and-Updates-Strategic-and-Operating-Plans-483650 <style type="text/css"> <!-- .bwcellpaddingbottom1 {padding-bottom: 2.0px} .bwcellpaddingbottom3 {padding-bottom: 4.0px} .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft2 {padding-left: 10.0px} .bwcellpaddingleft3 {padding-left: 15.0px} .bwcellpaddingleft4 ...http://www.finanzen.net/nachricht/aktien/Neurogen-Corporation-Announces-First-Quarter-2009-Financial-Results-and-Updates-Strategic-and-Operating-Plans-483650http://www.finanzen.net/nachricht/aktien/Neurogen-Corporation-Announces-Webcast-of-First-Quarter-2009-Financial-Results-on-May-12-2009-482411 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Neurogen Corporation (NASDAQ:NRGN), a drug development company, announced today that it will release its first quarter 2009 financial results ...http://www.finanzen.net/nachricht/aktien/Neurogen-Corporation-Announces-Webcast-of-First-Quarter-2009-Financial-Results-on-May-12-2009-482411http://www.finanzen.net/nachricht/aktien/Neurogen-Corporation-s-Auditors-Expressed-Going-Concern-Qualification-467336 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Neurogen Corporation (Nasdaq: NRGN) announced today that in its 2008 financial statements included in the Company’s Annual Report on Form ...http://www.finanzen.net/nachricht/aktien/Neurogen-Corporation-s-Auditors-Expressed-Going-Concern-Qualification-467336http://www.finanzen.net/nachricht/aktien/Neurogen-Corporation-Announces-2008-Financial-Results-457845 <style type="text/css"> <!-- .bwcellpaddingbottom1 {padding-bottom: 2.0px} .bwcellpaddingbottom3 {padding-bottom: 4.0px} .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft1 {padding-left: 5.0px} .bwcellpaddingleft2 {padding-left: 10.0px} .bwcellpaddingleft3 ...http://www.finanzen.net/nachricht/aktien/Neurogen-Corporation-Announces-2008-Financial-Results-457845http://www.finanzen.net/nachricht/aktien/Neurogen-Corporation-Announces-Webcast-of-Fourth-Quarter-2008-Financial-Results-on-March-19-2009-454052 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Neurogen Corporation (NASDAQ:NRGN), a drug development company, announced today that it will release its fourth quarter 2008 financial results ...http://www.finanzen.net/nachricht/aktien/Neurogen-Corporation-Announces-Webcast-of-Fourth-Quarter-2008-Financial-Results-on-March-19-2009-454052